BJMO - volume 11, issue 8, december 2017
J. Robijns PhD, S. Censabella , P. Bulens MD, A. Maes MD, L. Noé MD, M. Brosens , L. Van den Bergh MD, PhD, S. Claes , J. Mebis MD
Photobiomodulation therapy is based on the application of visible and/or (near-)infrared light on the target tissue. We performed a review of 34 articles on the use of photobiomodulation therapy in the management of cancer related lymphoedema, oral mucositis, radiodermatitis, chemotherapy-induced peripheral neuropathy, osteonecrosis of the jaw, and xerostomia/hyposalivation. The findings suggest that photobiomodulation therapy is a promising option for the management of these cancer therapy-related side effects.
(BELG J MED ONCOL 2017;11(8):364–374)
Read moreBJMO - volume 7, issue 5, december 2013
L. Van den Bergh MD, PhD
One of the obstacles for the adequate treatment of prostate cancer is the lack of reliable modalities to detect lymph node involvement in newly diagnosed patients. Until now, the only accurate solution is to perform an extended lymph node dissection. In this dissertation, investigated the role of choline positron emission tomography-computed tomography, diffusion-weighted magnetic resonance imaging and a sentinel node procedure for nodal staging were investigated showing that these novel approaches are not reliable enough to substitute for a lymphadenectomy. Furthermore, we reported which regions are of most importance if a staging lymphadenectomy is performed.
A second part, focused on the accurate localisation of the macroscopic tumour nodule within the prostate since delivering a higher radiation dose to this specific region might reduce the chances of local recurrence after radiotherapy. Therefore, the performance of the aforementioned imaging modalities were tested in the detection of intraprostatic tumour nodule(s). In conclusion, combining different functional magnetic resonance imaging modalities improved visualisation of the tumour but that the additional value of a positron emission tomography scan in this specific setting was limited.
(BELG J MED ONCOL 2013;7(5):156–58)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
